PSUSA/00002131/202503
PSUSA/00002131/202503
PSUSA/00002131/202503
Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 January 2026, 15:00 (CET) to 13 January 2026, 16:00 (CET)
PSUSA/00001500/202504
PSUSA/00003154/202505
PSUSA/00001509/202504
PSUSA/00001504/202504
Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Date of authorisation: 06/03/2025, Revision: 1, Status: Authorised
Q&A clinic on Substance, Organisation, Referentials Management Services - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 January 2026, 11:00 (CET) to 13 January 2026, 12:00 (CET)
PSUSA/00001503/202504